240 related articles for article (PubMed ID: 25886254)
1. The benefit of minocycline on negative symptoms in early-phase psychosis in addition to standard care - extent and mechanism (BeneMin): study protocol for a randomised controlled trial.
Lisiecka DM; Suckling J; Barnes TR; Chaudhry IB; Dazzan P; Husain N; Jones PB; Joyce EM; Lawrie SM; Upthegrove R; Deakin B
Trials; 2015 Mar; 16():71. PubMed ID: 25886254
[TBL] [Abstract][Full Text] [Related]
2. The benefit of minocycline on negative symptoms of schizophrenia in patients with recent-onset psychosis (BeneMin): a randomised, double-blind, placebo-controlled trial.
Deakin B; Suckling J; Barnes TRE; Byrne K; Chaudhry IB; Dazzan P; Drake RJ; Giordano A; Husain N; Jones PB; Joyce E; Knox E; Krynicki C; Lawrie SM; Lewis S; Lisiecka-Ford DM; Nikkheslat N; Pariante CM; Smallman R; Watson A; Williams SCR; Upthegrove R; Dunn G;
Lancet Psychiatry; 2018 Nov; 5(11):885-894. PubMed ID: 30322824
[TBL] [Abstract][Full Text] [Related]
3. A randomised, double-blind, placebo-controlled trial of minocycline and/or omega-3 fatty acids added to treatment as usual for at-risk mental states (NAYAB): study protocol.
Qurashi I; Chaudhry IB; Khoso AB; Farooque S; Lane S; Husain MO; Chu S; Sarginson J; Hamarani M; Naqvi HA; Razzaque B; Minhas FA; Yung AR; Deakin JFW; Husain N
Trials; 2017 Nov; 18(1):524. PubMed ID: 29121974
[TBL] [Abstract][Full Text] [Related]
4. Minocycline benefits negative symptoms in early schizophrenia: a randomised double-blind placebo-controlled clinical trial in patients on standard treatment.
Chaudhry IB; Hallak J; Husain N; Minhas F; Stirling J; Richardson P; Dursun S; Dunn G; Deakin B
J Psychopharmacol; 2012 Sep; 26(9):1185-93. PubMed ID: 22526685
[TBL] [Abstract][Full Text] [Related]
5. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
[TBL] [Abstract][Full Text] [Related]
6. Antipsychotic medication versus psychological intervention versus a combination of both in adolescents with first-episode psychosis (MAPS): a multicentre, three-arm, randomised controlled pilot and feasibility study.
Morrison AP; Pyle M; Maughan D; Johns L; Freeman D; Broome MR; Husain N; Fowler D; Hudson J; MacLennan G; Norrie J; Shiers D; Hollis C; James A;
Lancet Psychiatry; 2020 Sep; 7(9):788-800. PubMed ID: 32649925
[TBL] [Abstract][Full Text] [Related]
7. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
[TBL] [Abstract][Full Text] [Related]
8. Minocycline as an adjunct for treatment-resistant depressive symptoms: study protocol for a pilot randomised controlled trial.
Husain MI; Chaudhry IB; Rahman RR; Hamirani MM; Qurashi I; Khoso AB; Deakin JF; Husain N; Young AH
Trials; 2015 Sep; 16():410. PubMed ID: 26374703
[TBL] [Abstract][Full Text] [Related]
9. Switching antipsychotic medication to reduce sexual dysfunction in people with psychosis: the REMEDY RCT.
Crawford MJ; Thana L; Evans R; Carne A; O'Connell L; Claringbold A; Saravanamuthu A; Case R; Munjiza J; Jayacodi S; Reilly JG; Hughes E; Hoare Z; Barrett B; Leeson VC; Paton C; Keown P; Pappa S; Green C; Barnes TR
Health Technol Assess; 2020 Sep; 24(44):1-54. PubMed ID: 32930090
[TBL] [Abstract][Full Text] [Related]
10. Adjuvant therapy with minocycline for schizophrenia (The MINOS Trial): study protocol for a double-blind randomized placebo-controlled trial.
Fekadu A; Mesfin M; Medhin G; Alem A; Teferra S; Gebre-Eyesus T; Seboxa T; Assefa A; Hussein J; Lemma MT; Borba C; Henderson DC; Hanlon C; Shibre T
Trials; 2013 Nov; 14():406. PubMed ID: 24279305
[TBL] [Abstract][Full Text] [Related]
11. A randomised double-blind placebo-controlled trial of minocycline and/or omega-3 fatty acids added to treatment as usual for at risk Mental States: The NAYAB study.
Qurashi I; Chaudhry IB; Khoso AB; Omair Husain M; Hafeez D; Kiran T; Lane S; Naqvi HA; Minhas FA; Tamizuddin Nizami A; Razzaque B; Qambar Bokhari S; Yung AR; Deakin B; Husain N
Brain Behav Immun; 2024 Jan; 115():609-616. PubMed ID: 37924960
[TBL] [Abstract][Full Text] [Related]
12. Early intervention for psychosis.
Marshall M; Rathbone J
Cochrane Database Syst Rev; 2006 Oct; (4):CD004718. PubMed ID: 17054213
[TBL] [Abstract][Full Text] [Related]
13. Lansoprazole for persistent throat symptoms in secondary care: the TOPPITS RCT.
Wilson JA; Stocken DD; Watson GC; Fouweather T; McGlashan J; MacKenzie K; Carding P; Karagama Y; Harries M; Ball S; Khwaja S; Costello D; Wood R; Lecouturier J; O'Hara J
Health Technol Assess; 2021 Jan; 25(3):1-118. PubMed ID: 33492208
[TBL] [Abstract][Full Text] [Related]
14. Intravenous immunoglobulin and rituximab versus placebo treatment of antibody-associated psychosis: study protocol of a randomised phase IIa double-blinded placebo-controlled trial (SINAPPS2).
Lennox B; Yeeles K; Jones PB; Zandi M; Joyce E; Yu LM; Tomei G; Pollard R; Vincent SA; Shimazaki M; Cairns I; Dowling F; Kabir T; Barnes TRE; Lingford Hughes A; Hosseini AA; Harrower T; Buckley C; Coles A
Trials; 2019 Jun; 20(1):331. PubMed ID: 31174586
[TBL] [Abstract][Full Text] [Related]
15. Amisulpride for very late-onset schizophrenia-like psychosis: the ATLAS three-arm RCT.
Howard R; Cort E; Bradley R; Harper E; Kelly L; Bentham P; Ritchie C; Reeves S; Fawzi W; Livingston G; Sommerlad A; Oomman S; Nazir E; Nilforooshan R; Barber R; Fox C; Macharouthu A; Ramachandra P; Pattan V; Sykes J; Curran V; Katona C; Dening T; Knapp M; Romeo R; Gray R
Health Technol Assess; 2018 Nov; 22(67):1-62. PubMed ID: 30507375
[TBL] [Abstract][Full Text] [Related]
16. ENACT: a protocol for a randomised placebo-controlled trial investigating the efficacy and mechanisms of action of adjunctive N-acetylcysteine for first-episode psychosis.
Cotton SM; Berk M; Watson A; Wood S; Allott K; Bartholomeusz CF; Bortolasci CC; Walder K; O'Donoghue B; Dean OM; Chanen A; Amminger GP; McGorry PD; Burnside A; Uren J; Ratheesh A; Dodd S
Trials; 2019 Nov; 20(1):658. PubMed ID: 31779696
[TBL] [Abstract][Full Text] [Related]
17. CLEAR - clozapine in early psychosis: study protocol for a multi-centre, randomised controlled trial of clozapine vs other antipsychotics for young people with treatment resistant schizophrenia in real world settings.
Casetta C; Santosh P; Bayley R; Bisson J; Byford S; Dixon C; Drake RJ; Elvins R; Emsley R; Fung N; Hayes D; Howes O; James A; James K; Jones R; Killaspy H; Lennox B; Marchant L; McGuire P; Oloyede E; Rogdaki M; Upthegrove R; Walters J; Egerton A; MacCabe JH
BMC Psychiatry; 2024 Feb; 24(1):122. PubMed ID: 38355533
[TBL] [Abstract][Full Text] [Related]
18. Minocycline at 2 Different Dosages vs Placebo for Patients With Mild Alzheimer Disease: A Randomized Clinical Trial.
Howard R; Zubko O; Bradley R; Harper E; Pank L; O'Brien J; Fox C; Tabet N; Livingston G; Bentham P; McShane R; Burns A; Ritchie C; Reeves S; Lovestone S; Ballard C; Noble W; Nilforooshan R; Wilcock G; Gray R;
JAMA Neurol; 2020 Feb; 77(2):164-174. PubMed ID: 31738372
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
